UDIBI

Fecha de publicación: Marzo 2021 Poor survival in COVID-19 associated with Lymphopenia and Higher Neutrophile-Lymphocyte ratio Ver más

Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS

The yin/yang of inflammatory status: Blood-brain barrier regulation during sleep. VER MÁS

Regulatory Pathway for Licensing Biotherapeutics in Mexico. VER MÁS

Fecha de publicación: 16 mayo de 2019 Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract Transferon®) Ver...

Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....

The dialyzable leukocyte extract TransferonTM inhibits tumor growth and brain metastasis in a murine model of prostate cancer. VER...

Fecha de publicación: 20 Septiembre 2019 Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable...